Patent · US Active

DNA replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants

US8513397B2 · kind B2 · utility

8Cited by
2References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2009
Grant dateAug 20, 2013
Priority date
Expiry dateOct 23, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N15/8258
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Plant viral vectors have great potential in rapid production of proteins, but no simple. Here a geminivirus-based system for high-yield and rapid production of oligomeric protein complexes, including virus-like particle (VLP) vaccines and monoclonal antibodies (mAbs) is described. In particular, a single vector that contains two non-competing replicons for transient expression in Nicotiana benthamiana leaves is described. The correct assembly of these subunit proteins into functional oligomeric structures (VLPs or full-size mAb) is also described. This system advances plant transient expression technology by eliminating the need for non-competing viruses, and thus, enhances the realistic commercial application of this technology for producing multiple-subunit protein complexes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.